- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03055156
Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms
October 15, 2020 updated by: Seiji Nishino, Stanford University
The purpose of the study is to evaluate effects of high rebound mattress toppers (i.e., airweave®) on sleep and sleep-related symptoms.
The study will compare effects of use of high rebound mattress toppers versus use of low rebound mattress toppers on sleep and sleep related symptoms and core body temperature during diagnostic sleep studies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
558
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford Sleep Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults Age 18-65 who are scheduled for a diagnostic sleep study at the Stanford Sleep Clinic for sleep disorders (including but not limited to, insomnia, Sleep Apnea or other sleep disorder symptoms).
Exclusion Criteria:
- Individuals with a history of having difficulty swallowing food or large capsules. We will not be able to enroll individuals with any known or suspected obstructive disease of the gastrointestinal tract including, but not limited to esophageal stricture, diverticulosis and inflammatory bowel disease (IBD), peptic ulcer disease, Crohn's disease, ulcerative colitis, previous gastrointestinal surgery.
- Individuals who are pregnant.
- Individuals who are unable to provide informed consent (i.e. decisionally impaired).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low rebound mattress toppers
sleep with mattress topper during overnight diagnostic sleep study
|
Patients will sleep on this mattress topper during their diagnostic sleep study.
Other Names:
|
|
Experimental: High rebound mattress toppers
sleep with mattress topper during overnight diagnostic sleep study
|
Patients will sleep on this mattress topper during their diagnostic sleep study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Sleep Time
Time Frame: Overnight study visit (up to approximately 10hrs)
|
Overnight study visit (up to approximately 10hrs)
|
|
|
Sleep Efficiency Assessed by Polysomnography (PSG)
Time Frame: Overnight study visit (up to approximately 10hrs)
|
Sleep efficiency is total sleep time divided by time in bed.
All data were collected through the PSG data that were retrieved from the patients' medical records after completion of the recordings and analysis by the sleep technologists.
|
Overnight study visit (up to approximately 10hrs)
|
|
Sleep Latency Assessed by PSG
Time Frame: Overnight study visit (up to approximately 10hrs)
|
The amount of time from lights off to falling asleep.
|
Overnight study visit (up to approximately 10hrs)
|
|
Wake After Sleep Onset (WASO) Assessed by PSG
Time Frame: Overnight study visit (up to approximately 10hrs)
|
Total amount of minutes awake after the first sleep epoch.
|
Overnight study visit (up to approximately 10hrs)
|
|
Percentage of Time in Bed During Each Sleep Stage
Time Frame: Overnight study visit (up to approximately 10hrs)
|
Overnight study visit (up to approximately 10hrs)
|
|
|
Position Changes Assessed by PSG
Time Frame: Overnight study visit (up to approximately 10hrs)
|
Number of times participant changed position during the sleep recording.
|
Overnight study visit (up to approximately 10hrs)
|
|
Apnea Hypopnea Index Assessed by PSG
Time Frame: Overnight study visit (up to approximately 10hrs)
|
The number of apneas or hypopneas recorded during the study per hour of sleep.
|
Overnight study visit (up to approximately 10hrs)
|
|
Heart Rate
Time Frame: Overnight study visit (up to approximately 10hrs)
|
Overnight study visit (up to approximately 10hrs)
|
|
|
Periodic Leg Movements (PLM) During Sleep
Time Frame: Overnight study visit (up to approximately 10hrs)
|
Number of times participant had periodic leg movements during the sleep recording
|
Overnight study visit (up to approximately 10hrs)
|
|
Mean EEG Delta Spectral Power Per Second Over 90 Mins From Lights Off Between 0-360 Minutes After Lights Off
Time Frame: Overnight study visit (up to approximately 10hrs)
|
EEG data collected from the electrode in position C2
|
Overnight study visit (up to approximately 10hrs)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Core Body Temperature
Time Frame: Overnight study visit (up to approximately 10hrs)
|
Difference in core body temperature changes of the high and low rebound mattress toppers at sleep onset and during sleep.
The core body temperature will be monitored every minute throughout the night.
|
Overnight study visit (up to approximately 10hrs)
|
|
Visual Analog Scale of Sleep
Time Frame: Overnight study visit (up to approximately 10hrs)
|
visual analog scale of sleep was used for evaluation of subjective sleep quality.
Scale ranged from 0 cm (very bad) to 10 cm (very good).
|
Overnight study visit (up to approximately 10hrs)
|
|
Visual Analog Scale of Performance
Time Frame: Overnight study visit (up to approximately 10hrs)
|
visual analog scale of performance was used for evaluation of subjective performance quality.
Scale ranged from 0 cm (very bad) to 10 cm (very good).
|
Overnight study visit (up to approximately 10hrs)
|
|
Visual Analog Scale of Mood
Time Frame: Overnight study visit (up to approximately 10hrs)
|
visual analog scale of mood was used for evaluation of subjective mood.
Scale ranged from 0 cm (very bad) to 10 cm (very good).
|
Overnight study visit (up to approximately 10hrs)
|
|
Alliance Sleep Questionnaire (ASQ)
Time Frame: Overnight study visit (up to approximately 10hrs)
|
self-reported information related to sleep
|
Overnight study visit (up to approximately 10hrs)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Seiji Nishino, MD, PhD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (Actual)
October 19, 2019
Study Completion (Actual)
October 19, 2019
Study Registration Dates
First Submitted
August 26, 2015
First Submitted That Met QC Criteria
February 13, 2017
First Posted (Actual)
February 16, 2017
Study Record Updates
Last Update Posted (Actual)
November 6, 2020
Last Update Submitted That Met QC Criteria
October 15, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-34797
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disorders
-
Atlas UniversityCompletedSleep | Surgery | Sleep QualityTurkey (Türkiye)
-
Mersin UniversityCompletedSleep Quality | Sleep PerceptionTurkey (Türkiye)
-
Institute of Nutrition, Slovenia (Nutris)Valens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsNot yet recruitingSleep Quality | Sleep Onset LatencySlovenia
-
Mahidol UniversityRamathibodi HospitalNot yet recruitingSleep Inertia | Sleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | Night Shift WorkThailand
-
Athletic Greens InternationalRecruiting
-
Pharmavite LLCCompleted
-
Koko Home, Inc.Stanford UniversityRecruitingSleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Sleep HygieneUnited States
-
Aretaieion University HospitalRecruitingSleep Disorder | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Surgery | Anesthesia | Sleep Fragmentation | Sleep Disorders, Circadian RhythmGreece
-
The University of Hong KongNot yet recruiting
-
OmniSolutions Laboratory Holdings LimitedCompletedSleep Disturbance | Sleep QualityChina
Clinical Trials on Low rebound mattress toppers
-
Northeast Center for Rehabilitation and Brain InjuryProbed Medical USAUnknown
-
Charite University, Berlin, GermanyCompleted
-
SYSTAMClin-ExpertsRecruiting